EP4702011A1 - Composés antiviraux de 1,3-di-oxo-indène - Google Patents
Composés antiviraux de 1,3-di-oxo-indèneInfo
- Publication number
- EP4702011A1 EP4702011A1 EP24726860.0A EP24726860A EP4702011A1 EP 4702011 A1 EP4702011 A1 EP 4702011A1 EP 24726860 A EP24726860 A EP 24726860A EP 4702011 A1 EP4702011 A1 EP 4702011A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable salt
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
Abstract
L'invention concerne des composés de 1,3-dioxoindène tels que décrits dans la description, ainsi que des sels pharmaceutiquement acceptables, des compositions pharmaceutiques contenant de tels composés, et des procédés d'utilisation de ces composés, sels et compositions pour le traitement d'infections virales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363497972P | 2023-04-24 | 2023-04-24 | |
| PCT/US2024/025962 WO2024226581A1 (fr) | 2023-04-24 | 2024-04-24 | Composés antiviraux de 1,3-di-oxo-indène |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4702011A1 true EP4702011A1 (fr) | 2026-03-04 |
Family
ID=91129863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24726860.0A Pending EP4702011A1 (fr) | 2023-04-24 | 2024-04-24 | Composés antiviraux de 1,3-di-oxo-indène |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP4702011A1 (fr) |
| JP (1) | JP2026514931A (fr) |
| KR (1) | KR20260030710A (fr) |
| CN (1) | CN121335890A (fr) |
| AU (1) | AU2024263864A1 (fr) |
| CL (1) | CL2025003228A1 (fr) |
| CO (1) | CO2025014569A2 (fr) |
| CR (1) | CR20250451A (fr) |
| DO (1) | DOP2025000268A (fr) |
| IL (1) | IL323915A (fr) |
| MX (1) | MX2025012590A (fr) |
| PE (1) | PE20260292A1 (fr) |
| TW (1) | TW202506103A (fr) |
| WO (1) | WO2024226581A1 (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (fr) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Compositions pharmaceutiques a base d'un co-cristal |
| EA026149B1 (ru) | 2011-06-16 | 2017-03-31 | Корея Рисерч Инститьют Оф Кемикал Текнолоджи | Производное инданона, его фармацевтически приемлемая соль или оптический изомер, способ его получения и содержащая его фармацевтическая композиция для профилактики или лечения вирусного заболевания |
| US12286423B2 (en) | 2020-04-20 | 2025-04-29 | Novartis Ag | Antiviral 1,3-di-oxo-indene compounds |
-
2024
- 2024-04-23 TW TW113115072A patent/TW202506103A/zh unknown
- 2024-04-24 AU AU2024263864A patent/AU2024263864A1/en active Pending
- 2024-04-24 JP JP2025561998A patent/JP2026514931A/ja active Pending
- 2024-04-24 EP EP24726860.0A patent/EP4702011A1/fr active Pending
- 2024-04-24 PE PE2025002328A patent/PE20260292A1/es unknown
- 2024-04-24 KR KR1020257038785A patent/KR20260030710A/ko active Pending
- 2024-04-24 CR CR20250451A patent/CR20250451A/es unknown
- 2024-04-24 WO PCT/US2024/025962 patent/WO2024226581A1/fr not_active Ceased
- 2024-04-24 CN CN202480037180.2A patent/CN121335890A/zh active Pending
-
2025
- 2025-10-12 IL IL323915A patent/IL323915A/en unknown
- 2025-10-21 CO CONC2025/0014569A patent/CO2025014569A2/es unknown
- 2025-10-21 CL CL2025003228A patent/CL2025003228A1/es unknown
- 2025-10-21 DO DO2025000268A patent/DOP2025000268A/es unknown
- 2025-10-22 MX MX2025012590A patent/MX2025012590A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024263864A1 (en) | 2025-10-30 |
| CO2025014569A2 (es) | 2026-01-13 |
| CL2025003228A1 (es) | 2026-05-04 |
| WO2024226581A1 (fr) | 2024-10-31 |
| PE20260292A1 (es) | 2026-02-10 |
| KR20260030710A (ko) | 2026-03-06 |
| JP2026514931A (ja) | 2026-05-13 |
| CN121335890A (zh) | 2026-01-13 |
| DOP2025000268A (es) | 2026-01-30 |
| MX2025012590A (es) | 2025-11-03 |
| TW202506103A (zh) | 2025-02-16 |
| CR20250451A (es) | 2026-02-19 |
| IL323915A (en) | 2025-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4159211A1 (fr) | Composé présentant une activité physiologique telle qu'une activité antivirale | |
| US12286423B2 (en) | Antiviral 1,3-di-oxo-indene compounds | |
| JP2026076266A (ja) | 抗ウイルス1,3-ジ-オキソ-インデン化合物 | |
| CN118176202B (zh) | 一种含氰基取代的多肽类化合物的晶型及其制备方法 | |
| AU2024263864A1 (en) | Antiviral 1,3-di-oxo-indene compounds | |
| HK40130664A (en) | Antiviral 1,3-di-oxo-indene compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251107 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |